Clinical Trials Directory

Trials / Completed

CompletedNCT05231538

Neurodevelopmental Therapy for Spastic Cerebral Palsy

Effects of Neurodevelopment Therapy on Gross Motor Function and Postural Control in Children With Spastic Cerebral Palsy: A Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
66 (actual)
Sponsor
University of Lahore · Academic / Other
Sex
All
Age
2 Years – 6 Years
Healthy volunteers
Not accepted

Summary

This study was conducted to find out the Effects of Neurodevelopment therapy (a rehabilitative program designed by Bobath) on Gross Motor Function and Postural Control in Children with Spastic Cerebral Palsy. To investigate either there was a significant difference between the effects of neurodevelopment therapy and routine physical therapy on gross motor function and postural control in children with Spastic Cerebral Palsy.

Detailed description

A randomized controlled trial was conducted at Department of pediatric rehabilitation, Sher e Rabbani Hospital, Sheikhupura. Sample size was 66 and purposive sampling technique was adopted to collect data. Sample selection was completely based on inclusion and exclusion criteria. A diagnosed Spastic Cerebral Palsy patient aged 2-6 years with no other severe abnormalities such as seizure were recruited. While patients with mental retardation or undergone medical procedures likely to affect motor function such as botulinum toxin injections, orthopedic remedial surgery were excluded. Data was collected at baseline, 4th, 8th and 12th week of the treatment sessions. Gross motor function measure scale (GMFM-88) and posture and postural ability scale (PPAS) were used as data collection tools.

Conditions

Interventions

TypeNameDescription
OTHERNeurodevelopmental therapyNDT is a hands-on, 'problem solving approach'. It is used in the management and treatment of children who have disorders of function, movement or postural control because of damage in their central nervous system.
OTHERRoutine physical therapystretching, passive range of motion, and active range of motion).

Timeline

Start date
2021-06-17
Primary completion
2021-12-15
Completion
2021-12-31
First posted
2022-02-09
Last updated
2022-02-09

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT05231538. Inclusion in this directory is not an endorsement.